E Fund Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

E Fund Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,194	Closed	-$79.9K	–	374
2024 Q2	$79.9K	Sell	11,194 -13,643	-55%	-$104K	﹤0.01%	308
2024 Q1	$166K	Buy	24,837 +4,488	+22%	+$30.9K	0.01%	355
2023 Q4	$132K	Buy	+20,349	New	+$131K	0.01%	296
2023 Q3	–	Sell	-10,990	Closed	-$154K	–	324
2023 Q2	$154K	Buy	10,990 +953	+9%	+$16.2K	0.01%	288
2023 Q1	$188K	Sell	10,037 -6,691	-40%	-$110K	0.01%	308
2022 Q4	$230K	Buy	16,728 +4,749	+40%	+$72.7K	0.02%	278
2022 Q3	$229K	Sell	11,979 -2,015	-14%	-$36.7K	0.02%	278
2022 Q2	$214K	Buy	13,994 +3,159	+29%	+$46.7K	0.02%	292
2022 Q1	$221K	Buy	+10,835	New	+$221K	0.01%	276

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

E Fund Management's CDMO Position: Q3 2024 in Review

E Fund Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 11,194 shares — an estimated $79.9K sold.

E Fund Management first reported a position in CDMO in Q1 2022 and held it in 9 quarters. The position peaked at $230K in Q4 2022. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

E Fund Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
E Fund Management sold 11,194 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $79.9K.
E Fund Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
E Fund Management's Avid Bioservices, Inc. Common Stock position peaked at $230K in Q4 2022.
171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.